Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 100.49

-1.0%

Dec 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (2977)	12/9/2013 12:50:13 PM
From: scaram(o)uche	Read Replies (1) of 3202

>> early efficacy, panobinostat combo, to the presented at meeting << novartis.medicalcongressposters.com Unfortunately, there's no fibrosis data. Some patients from all dose escalation cohorts achieved 100% reduction in spleen size (palpation).... including all of them from the 25 TIW QOW/15 BID cohort. (Link from a guy who celebrates when a cancer vaccine trial does not meet initial objectives.)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next